{
  "background_dashed": [
    {
      "x": "Adolescents",
      "y": "Rest./repet. behaviors",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 20.5,
      "Outcome_group": "Core ASD symptoms",
      "customLabel": "In Adolescents (13-19 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Restricted/repetitive behaviors<\/u>. Based on the analysis of the quality of the evidence produced by the 5 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 5
    },
    {
      "x": "Adolescents",
      "y": "Social-communication",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 20.5,
      "Outcome_group": "Core ASD symptoms",
      "customLabel": "In Adolescents (13-19 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Social-communication<\/u>. Based on the analysis of the quality of the evidence produced by the 6 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 6
    },
    {
      "x": "Adolescents",
      "y": "Acceptability",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 20.5,
      "Outcome_group": "Safety",
      "customLabel": "In Adolescents (13-19 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Acceptability<\/u>. Based on the analysis of the quality of the evidence produced by the 9 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 9
    },
    {
      "x": "Adolescents",
      "y": "Adverse events",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 20.5,
      "Outcome_group": "Safety",
      "customLabel": "In Adolescents (13-19 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Adverse events<\/u>. Based on the analysis of the quality of the evidence produced by the 8 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 8
    },
    {
      "x": "School-age",
      "y": "Adverse events",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 20.5,
      "Outcome_group": "Safety",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Adverse events<\/u>. Based on the analysis of the quality of the evidence produced by the 4 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 4
    },
    {
      "x": "Adults",
      "y": "Adverse events",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 20.5,
      "Outcome_group": "Safety",
      "customLabel": "In Adults (>=20 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Adverse events<\/u>. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 2
    },
    {
      "x": "Adults",
      "y": "Quality of life",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 20.5,
      "Outcome_group": "Functioning",
      "customLabel": "In Adults (>=20 years old)  participants, there is <b>a small-to-moderate effect in favor of controls<\/b> on <u>Quality of life<\/u>. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 2
    },
    {
      "x": "Adults",
      "y": "ADHD symptoms",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 20.5,
      "Outcome_group": "Psych. comorbidity",
      "customLabel": "In Adults (>=20 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>ADHD symptoms<\/u>. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 2
    },
    {
      "x": "School-age",
      "y": "ADHD symptoms",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 20.5,
      "Outcome_group": "Psych. comorbidity",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>ADHD symptoms<\/u>. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 2
    },
    {
      "x": "Adults",
      "y": "Anxiety",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 20.5,
      "Outcome_group": "Psych. comorbidity",
      "customLabel": "In Adults (>=20 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Anxiety<\/u>. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 2
    },
    {
      "x": "Adolescents",
      "y": "Mood related symptoms",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 20.5,
      "Outcome_group": "Psych. comorbidity",
      "customLabel": "In Adolescents (13-19 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Mood related symptoms<\/u>. Based on the analysis of the quality of the evidence produced by the 4 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 4
    },
    {
      "x": "School-age",
      "y": "Disruptive behaviors",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 20.5,
      "Outcome_group": "ASD-related symptoms",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>a small-to-moderate effect in favor of OXYT<\/b> on <u>Disruptive behaviors<\/u>. Based on the analysis of the quality of the evidence produced by the 3 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 3
    },
    {
      "x": "Adults",
      "y": "Disruptive behaviors",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 20.5,
      "Outcome_group": "ASD-related symptoms",
      "customLabel": "In Adults (>=20 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Disruptive behaviors<\/u>. Based on the analysis of the quality of the evidence produced by the 3 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 3
    }
  ],
  "background": [
    {
      "x": "Adults",
      "y": "Overall ASD symptoms",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ad2b5b",
      "borderWidth": 3,
      "pointRadius": 20.5,
      "Outcome_group": "Core ASD symptoms",
      "customLabel": "In Adults (>=20 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Overall ASD symptoms<\/u>. Based on the analysis of the quality of the evidence produced by the 5 clinical trials exploring this effect, we have a <b>moderate confidence<\/b> in the estimation of this effect.",
      "n_studies": 5
    },
    {
      "x": "School-age",
      "y": "Overall ASD symptoms",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ad2b5b",
      "borderWidth": 3,
      "pointRadius": 20.5,
      "Outcome_group": "Core ASD symptoms",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Overall ASD symptoms<\/u>. Based on the analysis of the quality of the evidence produced by the 5 clinical trials exploring this effect, we have a <b>moderate confidence<\/b> in the estimation of this effect.",
      "n_studies": 5
    },
    {
      "x": "Adults",
      "y": "Rest./repet. behaviors",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ad2b5b",
      "borderWidth": 3,
      "pointRadius": 20.5,
      "Outcome_group": "Core ASD symptoms",
      "customLabel": "In Adults (>=20 years old)  participants, there is <b>a small-to-moderate effect in favor of OXYT<\/b> on <u>Restricted/repetitive behaviors<\/u>. Based on the analysis of the quality of the evidence produced by the 6 clinical trials exploring this effect, we have a <b>moderate confidence<\/b> in the estimation of this effect.",
      "n_studies": 6
    },
    {
      "x": "Adolescents",
      "y": "Rest./repet. behaviors",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 20.5,
      "Outcome_group": "Core ASD symptoms",
      "customLabel": "In Adolescents (13-19 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Restricted/repetitive behaviors<\/u>. Based on the analysis of the quality of the evidence produced by the 5 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 5
    },
    {
      "x": "School-age",
      "y": "Rest./repet. behaviors",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#de5c3a",
      "borderWidth": 1,
      "pointRadius": 20.5,
      "Outcome_group": "Core ASD symptoms",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Restricted/repetitive behaviors<\/u>. Based on the analysis of the quality of the evidence produced by the 5 clinical trials exploring this effect, we have a <b>low confidence<\/b> in the estimation of this effect.",
      "n_studies": 5
    },
    {
      "x": "Adolescents",
      "y": "Social-communication",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 20.5,
      "Outcome_group": "Core ASD symptoms",
      "customLabel": "In Adolescents (13-19 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Social-communication<\/u>. Based on the analysis of the quality of the evidence produced by the 6 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 6
    },
    {
      "x": "Adults",
      "y": "Social-communication",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#de5c3a",
      "borderWidth": 1,
      "pointRadius": 20.5,
      "Outcome_group": "Core ASD symptoms",
      "customLabel": "In Adults (>=20 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Social-communication<\/u>. Based on the analysis of the quality of the evidence produced by the 4 clinical trials exploring this effect, we have a <b>low confidence<\/b> in the estimation of this effect.",
      "n_studies": 4
    },
    {
      "x": "School-age",
      "y": "Social-communication",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#de5c3a",
      "borderWidth": 1,
      "pointRadius": 20.5,
      "Outcome_group": "Core ASD symptoms",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Social-communication<\/u>. Based on the analysis of the quality of the evidence produced by the 5 clinical trials exploring this effect, we have a <b>low confidence<\/b> in the estimation of this effect.",
      "n_studies": 5
    },
    {
      "x": "Adults",
      "y": "Acceptability",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ad2b5b",
      "borderWidth": 3,
      "pointRadius": 20.5,
      "Outcome_group": "Safety",
      "customLabel": "In Adults (>=20 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Acceptability<\/u>. Based on the analysis of the quality of the evidence produced by the 6 clinical trials exploring this effect, we have a <b>moderate confidence<\/b> in the estimation of this effect.",
      "n_studies": 6
    },
    {
      "x": "Adolescents",
      "y": "Acceptability",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 20.5,
      "Outcome_group": "Safety",
      "customLabel": "In Adolescents (13-19 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Acceptability<\/u>. Based on the analysis of the quality of the evidence produced by the 9 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 9
    },
    {
      "x": "School-age",
      "y": "Acceptability",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#de5c3a",
      "borderWidth": 1,
      "pointRadius": 20.5,
      "Outcome_group": "Safety",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Acceptability<\/u>. Based on the analysis of the quality of the evidence produced by the 6 clinical trials exploring this effect, we have a <b>low confidence<\/b> in the estimation of this effect.",
      "n_studies": 6
    },
    {
      "x": "Adolescents",
      "y": "Adverse events",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 20.5,
      "Outcome_group": "Safety",
      "customLabel": "In Adolescents (13-19 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Adverse events<\/u>. Based on the analysis of the quality of the evidence produced by the 8 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 8
    },
    {
      "x": "School-age",
      "y": "Adverse events",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 20.5,
      "Outcome_group": "Safety",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Adverse events<\/u>. Based on the analysis of the quality of the evidence produced by the 4 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 4
    },
    {
      "x": "Adults",
      "y": "Adverse events",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 20.5,
      "Outcome_group": "Safety",
      "customLabel": "In Adults (>=20 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Adverse events<\/u>. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 2
    },
    {
      "x": "Adults",
      "y": "Tolerability",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ad2b5b",
      "borderWidth": 3,
      "pointRadius": 20.5,
      "Outcome_group": "Safety",
      "customLabel": "In Adults (>=20 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Tolerability<\/u>. Based on the analysis of the quality of the evidence produced by the 6 clinical trials exploring this effect, we have a <b>moderate confidence<\/b> in the estimation of this effect.",
      "n_studies": 6
    },
    {
      "x": "School-age",
      "y": "Tolerability",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#de5c3a",
      "borderWidth": 1,
      "pointRadius": 20.5,
      "Outcome_group": "Safety",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Tolerability<\/u>. Based on the analysis of the quality of the evidence produced by the 6 clinical trials exploring this effect, we have a <b>low confidence<\/b> in the estimation of this effect.",
      "n_studies": 6
    },
    {
      "x": "Adults",
      "y": "Quality of life",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 20.5,
      "Outcome_group": "Functioning",
      "customLabel": "In Adults (>=20 years old)  participants, there is <b>a small-to-moderate effect in favor of controls<\/b> on <u>Quality of life<\/u>. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 2
    },
    {
      "x": "Adults",
      "y": "ADHD symptoms",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 20.5,
      "Outcome_group": "Psych. comorbidity",
      "customLabel": "In Adults (>=20 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>ADHD symptoms<\/u>. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 2
    },
    {
      "x": "School-age",
      "y": "ADHD symptoms",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 20.5,
      "Outcome_group": "Psych. comorbidity",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>ADHD symptoms<\/u>. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 2
    },
    {
      "x": "Adults",
      "y": "Anxiety",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 20.5,
      "Outcome_group": "Psych. comorbidity",
      "customLabel": "In Adults (>=20 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Anxiety<\/u>. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 2
    },
    {
      "x": "Adolescents",
      "y": "Mood related symptoms",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 20.5,
      "Outcome_group": "Psych. comorbidity",
      "customLabel": "In Adolescents (13-19 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Mood related symptoms<\/u>. Based on the analysis of the quality of the evidence produced by the 4 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 4
    },
    {
      "x": "School-age",
      "y": "Disruptive behaviors",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 20.5,
      "Outcome_group": "ASD-related symptoms",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>a small-to-moderate effect in favor of OXYT<\/b> on <u>Disruptive behaviors<\/u>. Based on the analysis of the quality of the evidence produced by the 3 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 3
    },
    {
      "x": "Adults",
      "y": "Disruptive behaviors",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 20.5,
      "Outcome_group": "ASD-related symptoms",
      "customLabel": "In Adults (>=20 years old)  participants, there is <b>no difference between OXYT and controls<\/b> on <u>Disruptive behaviors<\/u>. Based on the analysis of the quality of the evidence produced by the 3 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 3
    }
  ],
  "main": [
    {
      "x": "Adults",
      "y": "Overall ASD symptoms",
      "r": 12.5,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Core ASD symptoms"
    },
    {
      "x": "School-age",
      "y": "Overall ASD symptoms",
      "r": 12.5,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Core ASD symptoms"
    },
    {
      "x": "Adults",
      "y": "Rest./repet. behaviors",
      "r": 14,
      "backgroundColor": "#A2CDAE",
      "borderWidth": 0,
      "Outcome_group": "Core ASD symptoms"
    },
    {
      "x": "Adolescents",
      "y": "Rest./repet. behaviors",
      "r": 12.5,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Core ASD symptoms"
    },
    {
      "x": "School-age",
      "y": "Rest./repet. behaviors",
      "r": 12.5,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Core ASD symptoms"
    },
    {
      "x": "Adolescents",
      "y": "Social-communication",
      "r": 14,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Core ASD symptoms"
    },
    {
      "x": "Adults",
      "y": "Social-communication",
      "r": 11,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Core ASD symptoms"
    },
    {
      "x": "School-age",
      "y": "Social-communication",
      "r": 12.5,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Core ASD symptoms"
    },
    {
      "x": "Adults",
      "y": "Acceptability",
      "r": 14,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Safety"
    },
    {
      "x": "Adolescents",
      "y": "Acceptability",
      "r": 18.5,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Safety"
    },
    {
      "x": "School-age",
      "y": "Acceptability",
      "r": 14,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Safety"
    },
    {
      "x": "Adolescents",
      "y": "Adverse events",
      "r": 17,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Safety"
    },
    {
      "x": "School-age",
      "y": "Adverse events",
      "r": 11,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Safety"
    },
    {
      "x": "Adults",
      "y": "Adverse events",
      "r": 8,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Safety"
    },
    {
      "x": "Adults",
      "y": "Tolerability",
      "r": 14,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Safety"
    },
    {
      "x": "School-age",
      "y": "Tolerability",
      "r": 14,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Safety"
    },
    {
      "x": "Adults",
      "y": "Quality of life",
      "r": 8,
      "backgroundColor": "#DEADA7",
      "borderWidth": 0,
      "Outcome_group": "Functioning"
    },
    {
      "x": "Adults",
      "y": "ADHD symptoms",
      "r": 8,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Psych. comorbidity"
    },
    {
      "x": "School-age",
      "y": "ADHD symptoms",
      "r": 8,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Psych. comorbidity"
    },
    {
      "x": "Adults",
      "y": "Anxiety",
      "r": 8,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Psych. comorbidity"
    },
    {
      "x": "Adolescents",
      "y": "Mood related symptoms",
      "r": 11,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Psych. comorbidity"
    },
    {
      "x": "School-age",
      "y": "Disruptive behaviors",
      "r": 9.5,
      "backgroundColor": "#A2CDAE",
      "borderWidth": 0,
      "Outcome_group": "ASD-related symptoms"
    },
    {
      "x": "Adults",
      "y": "Disruptive behaviors",
      "r": 9.5,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "ASD-related symptoms"
    }
  ],
  "star": [
    {
      "x": "Adults",
      "y": "Rest./repet. behaviors",
      "backgroundColor": "red",
      "borderColor": "#red",
      "r": 19,
      "pointRadius": 14,
      "Outcome_group": "Core ASD symptoms"
    },
    {
      "x": "School-age",
      "y": "Disruptive behaviors",
      "backgroundColor": "red",
      "borderColor": "#red",
      "r": 14.5,
      "pointRadius": 9.5,
      "Outcome_group": "ASD-related symptoms"
    }
  ],
  "xLabels": ["Pre-school", "School-age", "Adolescents", "Adults"],
  "yLabels": ["Overall ASD symptoms", "Social-communication", "Rest./repet. behaviors", "Sensory Profile", "", "Acceptability", "Tolerability", "Adverse events", "", "Global cognition (IQ)", "Adaptive behaviors", "Quality of life", "Language (Overall)", "Language (Expressive)", "Language (Receptive)", "", "ADHD symptoms", "Anxiety", "Mood related symptoms", "", "Disruptive behaviors", "Sleep quality", "Sleep quantity"]
}
